Novelos | |
Novelos Therapeutics, Inc. was founded in 1996 to commercialize a promising, novel platform technology developed by BAM Ltd., a Russian biotechnology company. This platform has led to the identification of a novel class of metabolic modulators of cell cyc | |
Keywords : antibody, antibodies, AP1, BAM, BAM Ltd., BAM-002, BAM-CLN-01, biotechnology, blood, cancer, carboplatin, cell, cell cycle, cell function, cellular metabolism, cellular redox state, chemo, chemotherapy, chemotherapy courses, chemotherapy regimens, clinica |
Last Update : | 03/December/2011 |
Google PR : | 5 |
Indexed pages : | 258 |
Archive : | Check how did the site look in the past? |